Original Source(s)
Related Content
Neoadjuvant Chemo Did Not Improve Disease-Free Survival
Phase 3 NeoCol trial adds to mixed evidence as field shifts toward biomarker-guided approaches
May 1, 2026
-
5 min
Dalbavancin Exposure Linked to Higher Success in Bacteremia
Higher day 22 concentrations were associated with improved outcomes, though findings remain exploratory
May 6, 2026
-
4 min
Second Primary Cancer Risk Shifts Over Time
US registry study finds overall declines but rising risk in lung, melanoma, and older survivor groups
May 5, 2026
-
5 min